Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
m 1 revision imported
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
<noinclude>{{#set:
{{DocumentData
|DocReference=USA  FDA Guidance for Industry
Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects  Oct-2009
|DocValidityArea=USA
|DocScopes=G
|DocName=FDA Guidance for Industry
Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects
|DocVersion=Oct-2009
|DocStatus=Current
|DocType=Official recommendation
|DocLanguage=EN
|DocDescription=Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>
 
{{DocumentBox
|reference=USA  FDA Guidance for Industry
|reference=USA  FDA Guidance for Industry
Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects  Oct-2009
Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects  Oct-2009
Line 33: Line 16:
|contributors=
|contributors=
}}
}}
<noinclude>
== References ==
{| class="wikitable"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A.]] || G || III. A. || EN || III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES This section of the guidance clarifies the investigator’s responsibility to supervise the conduct of the clinical investigation and to ...
|-
| [[Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B.]] || G || III. B. || EN || III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES [...] B. Protecting the Rights, Safety, and Welfare of Study Subjects Investigators are responsible for protecting the rights, safety, and ...
|}
</noinclude>

Latest revision as of 14:15, 16 July 2026


Document information
Reference USA FDA Guidance for Industry

Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009

Validity area USA
Scope(s) G
Document name FDA Guidance for Industry

Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects

Version / Revision Oct-2009
Status Current
Document type Official recommendation
Language(s) EN
Description Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A.GIII. A.ENIII. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES This section of the guidance clarifies the investigator’s responsibility to supervise the…
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B.GIII. B.ENIII. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES

[...] B. Protecting the Rights, Safety, and Welfare of Study Subjects

Investigators are re…
Retrieved from "https://gxplex.org/index.php?title=Document:USA_FDA_Guidance_for_Industry_Investigator_Responsibilities_—_Protecting_the_Rights,_Safety,_and_Welfare_of_Study_Subjects_Oct-2009&oldid=20409"